Title: Greater China Consortium for Study of Hepatitis B Virus Immunopathogenesis and Immunity GCCSHBVII
1Greater China Consortium for Study of Hepatitis B
Virus Immunopathogenesis and Immunity
(GC-CS-HBVII)
- Greater China
- Non-profit
- Non-discriminatory
- Non-political
2Background
3Worldwide Prevalence of HBV and Incidence of HCC
World prevalence of HBV carriers
Annual incidence of primary HCC
HBsAg carriers-prevalence lt2 27 gt8 Poorly
documented
Cases/100,000 population 13 310 10150 Poorl
y documented
WHO 2003
4Hepatitis B Related Death in China
gt85 related to HBV infection
He et al. NEJM 2006
5HBV Host Relationship
Host genome profile
Immune system
- Viral kinetics
- HBV genotypes mutants
HBV
Disease progression with necroinflammation
Rx responder
Resolution
Rx non-responder
Liver Cancer
Rx-treatment
6Our Vision
Perfect tailor made therapy for chronic
hepatitis B
7Our Mission
- To offer innovative integrated molecular
diagnostic and research approaches for the
clinical management of chronic hepatitis B.
8Goals of HBV study
- To identify predictors of disease progression and
treatment response - To develop new therapies for viral hepatitis and
liver cancer - To promote high quality research into viral
hepatitis - To consolidate Greater China partnerships with
clinical, genetic, virological and immunological
expertise - To develop a comprehensive bioinformatics
resource for the management of chronic hepatitis B
9Founding Institutes
10Partnerships
Clinical GKK Lau, CM Lo, R Poon, CK Hui The
University of Hong Kong, Hong Kong
Immunology Fu Gao Chinese Academy of Sciences
Xiao-ming Gao Peking University Health Science
Centre Fang-ping Huang The University of Hong
Kong, Hong Kong Fu-Sheng Wang Beijing Institute
of Infectious Diseases
Virology Zhaung Hui Peking University Health
Science Center, Beijing
???
??
???
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
??
Genetic study William Mak, Pak Sham Genome
Research Centre, HKU
??
11Milestones